Daniel Weintraub

Daniel Weintraub

UNVERIFIED PROFILE

Are you Daniel Weintraub?   Register this Author

Register author
Daniel Weintraub

Daniel Weintraub

Publications by authors named "Daniel Weintraub"

Are you Daniel Weintraub?   Register this Author

99Publications

2789Reads

47Profile Views

Smaller subcortical volume in Parkinson patients with rapid eye movement sleep behavior disorder.

Brain Imaging Behav 2019 Oct;13(5):1352-1360

Department of Psychiatry, Amsterdam UMC, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11682-018-9939-4
Publisher Site
http://dx.doi.org/10.1007/s11682-018-9939-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395547PMC
October 2019

From action to abstraction: The sensorimotor grounding of metaphor in Parkinson's disease.

Cortex 2019 Oct 2;121:362-384. Epub 2019 Oct 2.

University of Pennsylvania, Philadelphia, PA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cortex.2019.09.005DOI Listing
October 2019

The Neuropsychiatry of Parkinson Disease: A Perfect Storm.

Am J Geriatr Psychiatry 2019 Sep 9;27(9):998-1018. Epub 2019 Mar 9.

Perelman School of Medicine (DW, EM), University of Pennsylvania, Philadelphia.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10647481193028
Publisher Site
http://dx.doi.org/10.1016/j.jagp.2019.03.002DOI Listing
September 2019

New evidence on the management of Lewy body dementia.

Lancet Neurol 2019 Sep 10. Epub 2019 Sep 10.

Department of Psychiatry, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1474-4422(19)30153-XDOI Listing
September 2019

The movement disorder society nonmotor rating scale: Initial validation study.

Mov Disord 2019 Sep 30. Epub 2019 Sep 30.

National Center of Epidemiology and CIBERNED, Carlos III Institute of Health, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.27862DOI Listing
September 2019

Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohorts.

Neurol Genet 2019 Aug 9;5(4):e348. Epub 2019 Jul 9.

Laboratory of Neurogenetics (H.I., C.B., H.L.L., F.F., D.G.H., A.B.S., M.A.N.), National Institute on Aging, National Institutes of Health, Bethesda; Data Tecnica International (H.I., M.A.N.), Glen Echo, MD; Precision Neurology Program (G.L., C.R.S.), Harvard Medical School, Brigham and Women's Hospital; Neurogenomics Laboratory (G.L., C.R.S.), Harvard Medical School, Brigham and Women's Hospital; Ann Romney Center for Neurologic Diseases (G.L., C.R.S.), Brigham and Women's Hospital, Boston, MA; The Norwegian Centre for Movement Disorders (J.M.-G., G.A.), Stavanger University Hospital; Department of Chemistry (J.M.-G., G.A.), Bioscience and Environmental Engineering, University of Stavanger, Norway; Assistance-Publique Hôpitaux de Paris (J.-C.C.), ICM, INSERM UMRS 1127, CNRS 7225, ICM, Department of Neurology and CIC Neurosciences, Pitié-Salpêtrière Hospital, Paris, France; Department of Neurology (L.P., M.T.), Oslo University Hospital, Norway; Department of Neurology (M.N., B.R.B., B.P.W.), Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands; Michael J Fox Foundation (S.J.H.), New York; Translational Genome Sciences (K.-D.H.N, K.E.), Biogen, Cambridge, MA; Department of Neurology University of Pennsylvania (J.R.), Philadelphia, PA; Department of Biostatistics and Computational Biology (S.E.), University of Rochester, NY; Department of Computer Science (F.F.), University of Illinois Urbana-Champaign; Department of Neurology (P.A.), Center for Health + Technology, University of Rochester, NY; Department of Clinical Neurosciences (K.M.S., R.W.), University of Cambridge, John van Geest Centre for Brain Repair, UK; Department of Pathology and Laboratory Medicine (V.M.V.D.), Center for Neurodegenerative Disease Research, Parelman School of Medicine at the University of Pennsylvania, Philadelphia; Genetics and Pharmacogenomics (A.G.D.-W.), Merck Research Laboratory, Boston, MA; Statistical Genetics (A.G.D.-W.), Biogen, Cambridge, MA; Institut du cerveau et de la moelle épinière ICM (A.B., F.D.); Sorbonne Université SU (A.B.); INSERM UMR (A.B.), Paris, France; Department of Neurology (G.A.), Stavanger University Hospital, Norway; Preventive Neurology Unit (A.J.N.), Wolfson Institute of Preventive Medicine, Queen Mary University of London; Department of Molecular Neuroscience (A.J.N.), UCL Institute of Neurology, London, UK; Department of Neurology (O.-B.T.), Haukeland University Hospital; University of Bergen (O.-B.T.), Bergen, Norway; Department of Neurology (J.R.E.), Nottingham University NHS Trust, UK; Centre for Clinical Brain Sciences (D.P.B.), University of Edinburgh; Anne Rowling Regenerative Neurology Clinic (D.P.B.), University of Edinburgh; Usher Institute of Population Health Sciences and Informatics (D.P.B.), University of Edinburgh, Scotland; Department of Medical and Molecular Genetics (C.E.W.), Indiana University, Indianapolis; Department of Neurology (D.K.S.), Beth Israel Deaconess Medical Center; Harvard Medical School (D.K.S.), Boston; Voyager Therapeutics (B.R.), Cambridge, MA; Department of Neurology (B.R.), University of Rochester School of Medicine, NY; Institute of Clinical Medicine (M.T.), University of Oslo, Norway; German Center for Neurodegenerative Diseases-Tubingen (P.H.); HIH Tuebingen (P.H.), Germany; Department of Psychiatry (D.W.), University of Pennsylvania School of Medicine; Department of Veterans Affairs (D.W.), Philadelphia, PA; and Department of Clinical Neurosciences (R.A.B., C.H.W.-G.), University of Cambridge, UK; Department of Neurology (J.J.V.H.), Leiden University Medical Center, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXG.0000000000000348DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659137PMC
August 2019

Integration and Extension of Specialty Mental Healthcare Services to Community Practice in Parkinson Disease.

Am J Geriatr Psychiatry 2019 Jul 13;27(7):712-719. Epub 2019 Mar 13.

Department of Neurology (GMP, ZM), Johns Hopkins University School of Medicine, Baltimore; Cleveland Clinic Lou Ruvo Center for Brain Health (ZM), Movement Disorders Program, Las Vegas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jagp.2019.03.005DOI Listing
July 2019

Lack of independent mood-enhancing effect for dopaminergic medications in early Parkinson's disease.

J Neurol Sci 2019 Jul 16;402:81-85. Epub 2019 May 16.

Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Department of Veterans Affairs, Philadelphia VA Medical Center, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2019.05.009DOI Listing
July 2019

Cognitive Functional Abilities in Parkinson's Disease: Agreement Between Patients and Informants.

Mov Disord Clin Pract 2019 Jul 17;6(6):440-445. Epub 2019 May 17.

Departments of Neurology, Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mdc3.12781DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660222PMC
July 2019

French validation of the questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale (QUIP-RS).

Parkinsonism Relat Disord 2019 Jun 4;63:117-123. Epub 2019 Mar 4.

Université Clermont Auvergne, NPsy-Sydo, CHRU Clermont-Ferrand, NS-Park/F-CRIN Network, Neurology Department, Clermont-Ferrand, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2019.02.026DOI Listing
June 2019

Cortical thinning in patients with REM sleep behavior disorder is associated with clinical progression.

NPJ Parkinsons Dis 2019 3;5. Epub 2019 May 3.

1Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41531-019-0079-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499806PMC
May 2019

Impulse control disorders in Parkinson's disease: A 20-year odyssey.

Authors:
Daniel Weintraub

Mov Disord 2019 04 26;34(4):447-452. Epub 2019 Mar 26.

Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.27668DOI Listing
April 2019

Altered large-scale functional brain networks in neurological Wilson's disease.

Brain Imaging Behav 2019 Apr 22. Epub 2019 Apr 22.

Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11682-019-00066-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810801PMC
April 2019

Pharmacological treatment of apathy in Lewy body disorders: A systematic review.

Parkinsonism Relat Disord 2019 03 5;60:14-24. Epub 2018 Nov 5.

Department of Neurology, University of Pennsylvania, Philadelphia, PA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2018.11.002DOI Listing
March 2019

Risk of Parkinson's disease dementia related to level I MDS PD-MCI.

Mov Disord 2019 03 17;34(3):430-435. Epub 2019 Jan 17.

Department of Medical Psychology, Academic Medical Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.27617DOI Listing
March 2019

Pilot Study of the International Parkinson and Movement Disorder Society-sponsored Non-motor Rating Scale (MDS-NMS).

Mov Disord Clin Pract 2019 Mar 5;6(3):227-234. Epub 2019 Feb 5.

Parkinson's Foundation International Centre of Excellence King's College Hospital London United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mdc3.12728DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417755PMC
March 2019

Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology.

Alzheimers Dement 2019 01 12;15(1):55-64. Epub 2018 Oct 12.

Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jalz.2018.08.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333489PMC
January 2019

Impulse Control Disorders in Parkinson's Disease.

Am J Psychiatry 2019 01;176(1):5-11

The Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia (Weintraub and Mamikonyan); and the Parkinson's Disease Research, Education, and Clinical Center and the Mental Illness Research, Education, and Clinical Center, Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia (Weintraub).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ajp.2018.18040465DOI Listing
January 2019

Validation of a performance-based assessment of cognitive functional ability in Parkinson's disease.

Mov Disord 2018 11 10;33(11):1760-1768. Epub 2018 Oct 10.

Department of Neurology, University of Colorado School of Medicine, Aurora, Colorado, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.27487DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261681PMC
November 2018

Cerebrospinal fluid α-synuclein contributes to the differential diagnosis of Alzheimer's disease.

Alzheimers Dement 2018 08 28;14(8):1052-1062. Epub 2018 Mar 28.

Department of Pathology, University of Washington School of Medicine, Seattle, WA, USA; Department of Pathology, Peking University Health Science Centre and Third Hospital, Beijing, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jalz.2018.02.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097943PMC
August 2018

Statins and Cognition in Parkinson's Disease.

J Parkinsons Dis 2017 ;7(4):661-667

Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/JPD-171113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675567PMC
June 2018

Quantitative assessment of finger tapping characteristics in mild cognitive impairment, Alzheimer's disease, and Parkinson's disease.

J Neurol 2018 Jun 4;265(6):1365-1375. Epub 2018 Apr 4.

Neuropsychiatry Section, Department of Psychiatry, 10th Floor, Gates Building, Hospital of the University of Pennsylvania, University of Pennsylvania Perelman School of Medicine, 3400 Spruce Street, Philadelphia, PA, 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-018-8841-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992087PMC
June 2018

Impulse Control and Related Disorders in Parkinson's Disease.

Int Rev Neurobiol 2017 1;133:679-717. Epub 2017 Jun 1.

Vanderbilt University School of Medicine, Nashville, TN, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/bs.irn.2017.04.006DOI Listing
April 2018

At a crossroads: Revisiting mild cognitive impairment in Parkinson's disease.

Mov Disord 2018 04 8;33(4):501-502. Epub 2018 Feb 8.

Department of Neurology, University of California San Diego, San Diego, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.27310DOI Listing
April 2018

Initial cognitive changes in Parkinson's disease.

Mov Disord 2018 04 15;33(4):511-519. Epub 2018 Mar 15.

Rush University Medical Center, Department of Neurological Sciences, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.27330DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920539PMC
April 2018

Reply: MoCA for cognitive screening in Parkinson's disease: Beware of floor effect.

Mov Disord 2018 03 20;33(3):499-500. Epub 2018 Feb 20.

National Centre of Epidemiology and CIBERNED, Carlos III Institute of Health, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.27339DOI Listing
March 2018

CSF tau and β-amyloid predict cerebral synucleinopathy in autopsied Lewy body disorders.

Neurology 2018 03 21;90(12):e1038-e1046. Epub 2018 Feb 21.

From Penn Frontotemporal Degeneration Center (D.J.I., N.N., C.T.M., M.G.), Alzheimer's Disease Core Center (D.A.W., J.Q.T.), Department of Neurology (D.J.I., D.C., R.S.A., C.T.M., D.A.W., D.W., A.C.-P., M.S., A.S., H.I.H., M.G.), Penn Morris K. Udall Parkinson's Disease Research Center of Excellence (D.J.I., R.S.A., C.T.M., D.W., A.C.-P., J.E.D., M.G., J.Q.T.), Center for Neurodegenerative Disease Research (L.M.S., J.Q.T.), Translational Neuropathology Research Laboratory (E.B.L.), Department of Pathology and Laboratory Medicine (E.B.L., L.M.S., J.Q.T.), and Department of Biostatistics and Epidemiology Perelman School of Medicine (S.X.X.), University of Pennsylvania; and Parkinson's Disease Research, Education and Clinical Center (D.W., J.E.D.), Michael J. Crescenz VA Medical Center, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://www.neurology.org/lookup/doi/10.1212/WNL.000000000000
Publisher Site
http://dx.doi.org/10.1212/WNL.0000000000005166DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874449PMC
March 2018

Global scales for cognitive screening in Parkinson's disease: Critique and recommendations.

Mov Disord 2018 02 23;33(2):208-218. Epub 2017 Nov 23.

National Centre of Epidemiology and CIBERNED, Carlos III Institute of Health, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.27233DOI Listing
February 2018

APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease.

Mov Disord 2018 02 23;33(2):289-297. Epub 2017 Nov 23.

Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.27204DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809205PMC
February 2018

Beyond Impressions: How Altered Shear Stress Connects Hypoxic Signaling to Endothelial Inflammation.

Arterioscler Thromb Vasc Biol 2017 11;37(11):1987-1989

From the Vascular Biology Center, Medical College of Georgia, Augusta University.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/ATVBAHA.117.310149DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662201PMC
November 2017

Predictors of anxiety in early-stage Parkinson's disease - Results from the first two years of a prospective cohort study.

Parkinsonism Relat Disord 2017 Oct 5;43:49-55. Epub 2017 Jul 5.

Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Department of Anatomy & Neurosciences, VU University Medical Centre, Amsterdam, The Netherlands; Amsterdam Neuroscience, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2017.06.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656500PMC
October 2017

Bridging cognitive screening tests in neurologic disorders: A crosswalk between the short Montreal Cognitive Assessment and Mini-Mental State Examination.

Alzheimers Dement 2017 Aug 24;13(8):947-952. Epub 2017 Feb 24.

Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Alzheimer's Disease Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jalz.2017.01.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5554086PMC
August 2017

Antipsychotic Use and Physical Morbidity in Parkinson Disease.

Am J Geriatr Psychiatry 2017 Jul 2;25(7):697-705. Epub 2017 Feb 2.

Department of Veterans Affairs, HSR&D Center for Clinical Management Research, Ann Arbor, MI, USA; Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA; Geriatric Research, Education and Clinical Center, VA Ann Arbor Healthcare System, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jagp.2017.01.076DOI Listing
July 2017

The bidirectional longitudinal relationship between insomnia, depression and anxiety in patients with early-stage, medication-naïve Parkinson's disease.

Parkinsonism Relat Disord 2017 06 1;39:31-36. Epub 2017 Feb 1.

Department of Psychiatry, VU University Medical Center (VUmc), The Netherlands; Department of Anatomy & Neurosciences, VUmc, The Netherlands; Amsterdam Neuroscience, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2017.01.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441947PMC
June 2017

Cognitive decline in Parkinson disease.

Nat Rev Neurol 2017 Apr 3;13(4):217-231. Epub 2017 Mar 3.

KCL-PARCOG group, Institute of Psychiatry, Psychology &Neuroscience, King's College London, De Crespigny Park, London SE5 8AF, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrneurol.2017.27DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643027PMC
April 2017

Risk factors for early psychosis in PD: insights from the Parkinson's Progression Markers Initiative.

J Neurol Neurosurg Psychiatry 2017 Apr;88(4):325-331

KCL-PARCOG Group, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jnnp-2016-314832DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362125PMC
April 2017

Cognitive decline before diagnosis of Parkinson's disease - Authors' reply.

Lancet Neurol 2017 04;16(4):262

UCL Institute of Neurology, University College London, London.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1474-4422(17)30043-1DOI Listing
April 2017

Impulse Control Disorders and Related Complications of Parkinson's Disease Therapy.

Semin Neurol 2017 04 16;37(2):186-192. Epub 2017 May 16.

Department of Neurology, Vanderbilt University, Nashville, Tennessee.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0037-1601887DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516267PMC
April 2017

The depressed brain in Parkinson's disease: Implications for an inflammatory biomarker.

Proc Natl Acad Sci U S A 2017 03 10;114(12):3004-3005. Epub 2017 Mar 10.

Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA 19104.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1700737114DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373331PMC
March 2017

The psychosis spectrum in Parkinson disease.

Nat Rev Neurol 2017 Feb 20;13(2):81-95. Epub 2017 Jan 20.

KCL-PARCOG group, Institute of Psychiatry, Psychology &Neuroscience, King's College London, De Crespigny Park, London SE5 8AF, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrneurol.2016.200DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656278PMC
February 2017

Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study.

Lancet Neurol 2017 Jan 18;16(1):66-75. Epub 2016 Nov 18.

Dementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1474-4422(16)30328-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5377592PMC
January 2017

Decision-Making Deficits Associated with Amyloidosis in Lewy Body Disorders.

Front Hum Neurosci 2016 11;10:693. Epub 2017 Jan 11.

Penn Frontotemporal Degeneration Center, University of Pennsylvania Perelman School of Medicine Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fnhum.2016.00693DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225123PMC
January 2017

Clinical-genetic model predicts incident impulse control disorders in Parkinson's disease.

J Neurol Neurosurg Psychiatry 2016 Oct 13;87(10):1106-11. Epub 2016 Apr 13.

Sorbonne Universités, UPMC Univ Paris 06, and INSERM UMRS_1127 and CIC_1422, and CNRS UMR_7225, and AP-HP, and ICM, Département des maladies du système nerveux and Département de Génétique, Hôpital Pitié-Salpêtrière, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jnnp-2015-312848DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098340PMC
October 2016

The Danger of Not Treating Parkinson Disease Psychosis-Reply.

JAMA Neurol 2016 09;73(9):1156-7

Morton and Gloria Shulman Movement Disorder Centre, The Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaneurol.2016.2274DOI Listing
September 2016

Progress Regarding Parkinson's Disease Psychosis: It's No Illusion.

Authors:
Daniel Weintraub

Mov Disord Clin Pract 2016 Sep-Oct;3(5):431-434. Epub 2016 Aug 11.

Departments of Psychiatry and Neurology University of Pennsylvania School of Medicine Philadelphia Pennsylvania USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mdc3.12377DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178612PMC
August 2016

The Case for Antipsychotics in Dementia with Lewy Bodies.

Mov Disord Clin Pract 2017 Jan-Feb;4(1):32-35. Epub 2016 Jun 24.

Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mdc3.12383DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353494PMC
June 2016

High patient satisfaction with telehealth in Parkinson disease: A randomized controlled study.

Neurol Clin Pract 2016 Jun;6(3):241-251

Parkinson's Disease Research, Education and Clinical Center (PADRECC) (JRW, MS, SMW, DW, JFM, JED), Philadelphia Veterans Affairs Medical Center, Philadelphia, PA; Department of Neurology (JRW, MS, DW, JFM, JED), Department of Psychiatry (DW), and Department of Physical Medicine Rehabilitation (MGS), Perelman School of Medicine of the University of Pennsylvania, Philadelphia; and School of Social Policy and Practice (SCM), University of Pennsylvania, Philadelphia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/CPJ.0000000000000252DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909521PMC
June 2016

Rasagiline for mild cognitive impairment in Parkinson's disease: A placebo-controlled trial.

Mov Disord 2016 05 31;31(5):709-14. Epub 2016 Mar 31.

Teva Pharmaceuticals, Overland Park, Kansas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.26617DOI Listing
May 2016

Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer's Dementia: Evidence From the CitAD Study.

Am J Psychiatry 2016 May 1;173(5):473-80. Epub 2016 Apr 1.

From the Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore; the Johns Hopkins Bloomberg School of Public Health, Baltimore; the Alzheimer's Disease Care, Research, and Education Program, University of Rochester School of Medicine and Dentistry, Rochester, N.Y.; the Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford; the Division of Geriatric Psychiatry, Department of Psychiatry, New York State Psychiatric Institute and College of Physicians and Surgeons of Columbia University, New York; the Clinical Biotechnology Research Institute, Roper St. Francis Healthcare, and the Department of Psychiatry, Ralph H. Johnson VA Medical Center, Charleston, S.C.; the Campbell Institute, Centre for Addiction and Mental Health, and the Department of Psychiatry, University of Toronto, Toronto; the Department of Psychiatry and Behavioral Sciences and the Department of Neurology, Keck School of Medicine of University of Southern California, Los Angeles; and the Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ajp.2016.15020248DOI Listing
May 2016

Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease.

Ann Clin Transl Neurol 2016 05 29;3(5):346-55. Epub 2016 Mar 29.

Department of Neurology Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acn3.299DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863747PMC
May 2016

Development and Validation of the Parkinson's Disease Medication Beliefs Scale (PD-Rx).

J Parkinsons Dis 2016 04;6(2):383-92

University of Pennsylvania Perelman School of Medicine, Department of Medicine, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/JPD-150765DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884139PMC
April 2016

Amyloid-Beta Positron Emission Tomography Imaging of Alzheimer's Pathology in Parkinson's Disease Dementia.

Mov Disord Clin Pract 2016 Jul-Aug;3(4):367-375. Epub 2016 Jan 5.

Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-3339, USA; Avid Radiopharmaceuticals, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mdc3.12290DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971540PMC
January 2016